Hester Biosciences submits transcript of earnings conference call

10 Feb 2020 Evaluate

Hester Biosciences has informed that the Company submitted a transcript of Earnings Conference Call held by the Management of the Company with investors on Friday, 7 February 2020 at 2.00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended on 31 December 2019.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1415.00 -12.50 (-0.88%)
20-Mar-2026 12:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.80
Dr. Reddys Lab 1294.50
Cipla 1256.75
Zydus Lifesciences 888.35
Lupin 2311.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×